Cargando…

Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa

BACKGROUND: Pseudomonas aeruginosa is an opportunistic pathogen involved in number of hospital-acquired infections such as catheter-associated urinary tract infections, bacteremia, septicemia, skin infections, and ventilator-associated pneumoniae. Biofilm formation is an important trait implicated i...

Descripción completa

Detalles Bibliográficos
Autores principales: Usman, Muhammad, Marcus, Arooj, Fatima, Aimen, Aslam, Bushra, Zaid, Maryam, Khattak, Muska, Bashir, Sidra, Masood, Safia, Rafaque, Zara, Dasti, Javid Iqbal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485136/
https://www.ncbi.nlm.nih.gov/pubmed/37692466
http://dx.doi.org/10.2147/IDR.S426111
_version_ 1785102728532328448
author Usman, Muhammad
Marcus, Arooj
Fatima, Aimen
Aslam, Bushra
Zaid, Maryam
Khattak, Muska
Bashir, Sidra
Masood, Safia
Rafaque, Zara
Dasti, Javid Iqbal
author_facet Usman, Muhammad
Marcus, Arooj
Fatima, Aimen
Aslam, Bushra
Zaid, Maryam
Khattak, Muska
Bashir, Sidra
Masood, Safia
Rafaque, Zara
Dasti, Javid Iqbal
author_sort Usman, Muhammad
collection PubMed
description BACKGROUND: Pseudomonas aeruginosa is an opportunistic pathogen involved in number of hospital-acquired infections such as catheter-associated urinary tract infections, bacteremia, septicemia, skin infections, and ventilator-associated pneumoniae. Biofilm formation is an important trait implicated in chronic infections, such as cystic fibrosis and chronic pulmonary obstruction. We evaluated effects of gentamicin, cefepime, and ciprofloxacin on biofilm of P. aeruginosa. MATERIALS AND METHODS: A total of 266 isolates were collected from the Armed Forces Institute of Pathology (AFIP). Antibiotic susceptibility was assessed by double disk synergy testing. ESBL and carbapenemase detection was performed by phenotypic testing. Molecular screening of the genes was done by PCR. Micro-dilution broth method was used to determine minimum inhibitory concentrations of antibiotics. Biofilm formation was done by micro-titer plate assay. RESULTS: Overall, 20% of the P. aeruginosa isolates were extensively drug-resistant (XDR-PA), and 25% were multi-drug-resistant (MDR-PA). Likewise, 43% of the isolates were ESBL producers, and carbapenemase production was detected in 40% of the isolates. Molecular analysis confirmed occurrence of different resistant factors in ESBL-positive isolates; 67% carried bla(TEM), 62% bla(CTXM-15), 41% bla(SHV), 34% bla(CTXM-14), and 33% bla(OXA-1). In addition, 68% of the carbapenem-resistant isolates were positive for bla(NDM-1), 25% for bla(OXA-48), and 22% for bla(KPC-2). Biofilm formation was assessed for 234 isolates, out of which 28% were strong biofilm formers. Moderate and weak biofilm formers constituted 46% and 23%, respectively. Overall, ciprofloxacin, levofloxacin, and cefepime showed inhibitory effects on P. aeruginosa biofilms. Antibiotics in combination showed strong synergistic effects (ciprofloxacin and cefepime), while gentamicin and cefepime resulted in complete eradication of P. aeruginosa biofilm. CONCLUSION: We confirm strong synergistic effects of gentamicin and cefepime that completely eradicated P. aeruginosa biofilm. We further confirm inhibitory effects of ciprofloxacin, levofloxacin, and cefepime on P. aeruginosa biofilms. Hence, combination therapy can be more effective against biofilm-associated infections.
format Online
Article
Text
id pubmed-10485136
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-104851362023-09-09 Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa Usman, Muhammad Marcus, Arooj Fatima, Aimen Aslam, Bushra Zaid, Maryam Khattak, Muska Bashir, Sidra Masood, Safia Rafaque, Zara Dasti, Javid Iqbal Infect Drug Resist Original Research BACKGROUND: Pseudomonas aeruginosa is an opportunistic pathogen involved in number of hospital-acquired infections such as catheter-associated urinary tract infections, bacteremia, septicemia, skin infections, and ventilator-associated pneumoniae. Biofilm formation is an important trait implicated in chronic infections, such as cystic fibrosis and chronic pulmonary obstruction. We evaluated effects of gentamicin, cefepime, and ciprofloxacin on biofilm of P. aeruginosa. MATERIALS AND METHODS: A total of 266 isolates were collected from the Armed Forces Institute of Pathology (AFIP). Antibiotic susceptibility was assessed by double disk synergy testing. ESBL and carbapenemase detection was performed by phenotypic testing. Molecular screening of the genes was done by PCR. Micro-dilution broth method was used to determine minimum inhibitory concentrations of antibiotics. Biofilm formation was done by micro-titer plate assay. RESULTS: Overall, 20% of the P. aeruginosa isolates were extensively drug-resistant (XDR-PA), and 25% were multi-drug-resistant (MDR-PA). Likewise, 43% of the isolates were ESBL producers, and carbapenemase production was detected in 40% of the isolates. Molecular analysis confirmed occurrence of different resistant factors in ESBL-positive isolates; 67% carried bla(TEM), 62% bla(CTXM-15), 41% bla(SHV), 34% bla(CTXM-14), and 33% bla(OXA-1). In addition, 68% of the carbapenem-resistant isolates were positive for bla(NDM-1), 25% for bla(OXA-48), and 22% for bla(KPC-2). Biofilm formation was assessed for 234 isolates, out of which 28% were strong biofilm formers. Moderate and weak biofilm formers constituted 46% and 23%, respectively. Overall, ciprofloxacin, levofloxacin, and cefepime showed inhibitory effects on P. aeruginosa biofilms. Antibiotics in combination showed strong synergistic effects (ciprofloxacin and cefepime), while gentamicin and cefepime resulted in complete eradication of P. aeruginosa biofilm. CONCLUSION: We confirm strong synergistic effects of gentamicin and cefepime that completely eradicated P. aeruginosa biofilm. We further confirm inhibitory effects of ciprofloxacin, levofloxacin, and cefepime on P. aeruginosa biofilms. Hence, combination therapy can be more effective against biofilm-associated infections. Dove 2023-09-06 /pmc/articles/PMC10485136/ /pubmed/37692466 http://dx.doi.org/10.2147/IDR.S426111 Text en © 2023 Usman et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Usman, Muhammad
Marcus, Arooj
Fatima, Aimen
Aslam, Bushra
Zaid, Maryam
Khattak, Muska
Bashir, Sidra
Masood, Safia
Rafaque, Zara
Dasti, Javid Iqbal
Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa
title Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa
title_full Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa
title_fullStr Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa
title_full_unstemmed Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa
title_short Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa
title_sort synergistic effects of gentamicin, cefepime, and ciprofloxacin on biofilm of pseudomonas aeruginosa
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485136/
https://www.ncbi.nlm.nih.gov/pubmed/37692466
http://dx.doi.org/10.2147/IDR.S426111
work_keys_str_mv AT usmanmuhammad synergisticeffectsofgentamicincefepimeandciprofloxacinonbiofilmofpseudomonasaeruginosa
AT marcusarooj synergisticeffectsofgentamicincefepimeandciprofloxacinonbiofilmofpseudomonasaeruginosa
AT fatimaaimen synergisticeffectsofgentamicincefepimeandciprofloxacinonbiofilmofpseudomonasaeruginosa
AT aslambushra synergisticeffectsofgentamicincefepimeandciprofloxacinonbiofilmofpseudomonasaeruginosa
AT zaidmaryam synergisticeffectsofgentamicincefepimeandciprofloxacinonbiofilmofpseudomonasaeruginosa
AT khattakmuska synergisticeffectsofgentamicincefepimeandciprofloxacinonbiofilmofpseudomonasaeruginosa
AT bashirsidra synergisticeffectsofgentamicincefepimeandciprofloxacinonbiofilmofpseudomonasaeruginosa
AT masoodsafia synergisticeffectsofgentamicincefepimeandciprofloxacinonbiofilmofpseudomonasaeruginosa
AT rafaquezara synergisticeffectsofgentamicincefepimeandciprofloxacinonbiofilmofpseudomonasaeruginosa
AT dastijavidiqbal synergisticeffectsofgentamicincefepimeandciprofloxacinonbiofilmofpseudomonasaeruginosa